Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a promising treatment approach for patients with peritoneal carcinomatosis, particularly ...

New Data Highlight Continued Potential of Radspherin to Prevent Disease Progression OSLO, Norway, Oct. 8, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company developing ...

Image Caption: Proteomic alterations in post-NACT OCPM tissues. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the ...

Comparison of long-term outcomes for neoadjuvant chemoradiation (NA-CRT) followed by surgery versus (V) definitive chemoradiation (D-CRT) in localized gastroesophageal cancer (GEC): A single-center ...

Ovarian cancer represents the most lethal gynecological malignancy, with most patients presenting peritoneal metastasis at diagnosis and demonstrating poor therapeutic response. The five-year survival ...

Medically reviewed by Doru Paul, MD Key Takeaways Peritoneal cancer is a rare cancer that starts in the thin tissue lining the abdomen.Symptoms often appear late and can include abdominal pain, ...

Chemotherapy drugs are administered via a port system in the abdominal cavity. The MHH is one of the first clinics in Germany to establish this method.

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study This is a single-institution ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...